Literature DB >> 27146725

New Nordic Diet versus Average Danish Diet: A Randomized Controlled Trial Revealed Healthy Long-Term Effects of the New Nordic Diet by GC-MS Blood Plasma Metabolomics.

Bekzod Khakimov1, Sanne Kellebjerg Poulsen2, Francesco Savorani1, Evrim Acar1, Gözde Gürdeniz2, Thomas M Larsen2, Arne Astrup2, Lars O Dragsted2, Søren Balling Engelsen1.   

Abstract

A previous study has shown effects of the New Nordic Diet (NND) to stimulate weight loss and lower systolic and diastolic blood pressure in obese Danish women and men in a randomized, controlled dietary intervention study. This work demonstrates long-term metabolic effects of the NND as compared with an Average Danish Diet (ADD) in blood plasma and reveals associations between metabolic changes and health beneficial effects of the NND including weight loss. A total of 145 individuals completed the intervention and blood samples were taken along with clinical examinations before the intervention started (week 0) and after 12 and 26 weeks. The plasma metabolome was measured using GC-MS, and the final metabolite table contained 144 variables. Significant and novel metabolic effects of the diet, resulting weight loss, gender, and intervention study season were revealed using PLS-DA and ASCA. Several metabolites reflecting specific differences in the diets, especially intake of plant foods and seafood, and in energy metabolism related to ketone bodies and gluconeogenesis formed the predominant metabolite pattern discriminating the intervention groups. Among NND subjects, higher levels of vaccenic acid and 3-hydroxybutanoic acid were related to a higher weight loss, while higher concentrations of salicylic, lactic, and N-aspartic acids and 1,5-anhydro-d-sorbitol were related to a lower weight loss. Specific gender and seasonal differences were also observed. The study strongly indicates that healthy diets high in fish, vegetables, fruit, and whole grain facilitated weight loss and improved insulin sensitivity by increasing ketosis and gluconeogenesis in the fasting state.

Entities:  

Keywords:  ASCA; PARAFAC2; PLS-DA; biomarker; diet; health benefit; metabolomics; weight loss

Mesh:

Year:  2016        PMID: 27146725     DOI: 10.1021/acs.jproteome.6b00109

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  12 in total

Review 1.  Nutritional Metabolomics in Cancer Epidemiology: Current Trends, Challenges, and Future Directions.

Authors:  Emma E McGee; Rama Kiblawi; Mary C Playdon; A Heather Eliassen
Journal:  Curr Nutr Rep       Date:  2019-09

Review 2.  Nutritional Metabolomics and the Classification of Dietary Biomarker Candidates: A Critical Review.

Authors:  Talha Rafiq; Sandi M Azab; Koon K Teo; Lehana Thabane; Sonia S Anand; Katherine M Morrison; Russell J de Souza; Philip Britz-McKibbin
Journal:  Adv Nutr       Date:  2021-12-01       Impact factor: 8.701

3.  Biomarkers of dietary patterns: a systematic review of randomized controlled trials.

Authors:  Shuang Liang; Reeja F Nasir; Kim S Bell-Anderson; Clémence A Toniutti; Fiona M O'Leary; Michael R Skilton
Journal:  Nutr Rev       Date:  2022-07-07       Impact factor: 6.846

4.  From metabolome to phenotype: GC-MS metabolomics of developing mutant barley seeds reveals effects of growth, temperature and genotype.

Authors:  Bekzod Khakimov; Morten Arendt Rasmussen; Rubini Maya Kannangara; Birthe Møller Jespersen; Lars Munck; Søren Balling Engelsen
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

5.  Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients.

Authors:  Adriano Aquino; Guilherme L Alexandrino; Paul C Guest; Fabio Augusto; Alexandre F Gomes; Michael Murgu; Johann Steiner; Daniel Martins-de-Souza
Journal:  Front Psychiatry       Date:  2018-05-25       Impact factor: 4.157

6.  Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake.

Authors:  Victoria Meslier; Manolo Laiola; Henrik Munch Roager; Francesca De Filippis; Hugo Roume; Benoit Quinquis; Rosalba Giacco; Ilario Mennella; Rosalia Ferracane; Nicolas Pons; Edoardo Pasolli; Angela Rivellese; Lars Ove Dragsted; Paola Vitaglione; Stanislav Dusko Ehrlich; Danilo Ercolini
Journal:  Gut       Date:  2020-02-19       Impact factor: 23.059

7.  Potential Markers of Dietary Glycemic Exposures for Sustained Dietary Interventions in Populations without Diabetes.

Authors:  Edith Feskens; Lorraine Brennan; Pierre Dussort; Matthieu Flourakis; Lena M E Lindner; David Mela; Naila Rabbani; Wolfgang Rathmann; Frédérique Respondek; Coen Stehouwer; Stephan Theis; Paul Thornalley; Sophie Vinoy
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

8.  Metabolic Trajectories Following Contrasting Prudent and Western Diets from Food Provisions: Identifying Robust Biomarkers of Short-Term Changes in Habitual Diet.

Authors:  Nadine Wellington; Meera Shanmuganathan; Russell J de Souza; Michael A Zulyniak; Sandi Azab; Jonathon Bloomfield; Alicia Mell; Ritchie Ly; Dipika Desai; Sonia S Anand; Philip Britz-McKibbin
Journal:  Nutrients       Date:  2019-10-09       Impact factor: 5.717

Review 9.  A Scoping Review: Metabolomics Signatures Associated with Animal and Plant Protein Intake and Their Potential Relation with Cardiometabolic Risk.

Authors:  Gaïa Lépine; Hélène Fouillet; Didier Rémond; Jean-François Huneau; François Mariotti; Sergio Polakof
Journal:  Adv Nutr       Date:  2021-12-01       Impact factor: 11.567

10.  Identification of weak and gender specific effects in a short 3 weeks intervention study using barley and oat mixed linkage β-glucan dietary supplements: a human fecal metabolome study by GC-MS.

Authors:  Alessia Trimigno; Bekzod Khakimov; Josue Leonardo Castro Mejia; Mette Skau Mikkelsen; Mette Kristensen; Birthe Møller Jespersen; Søren Balling Engelsen
Journal:  Metabolomics       Date:  2017-08-18       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.